Suchergebnisse - "Gyawali, Bishal"

PubPharm (308)

101

Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology : A Systematic Review with a Meta-Analysis

enthalten in: Targeted oncology | 2021

von Strzebonska, K. | Wasylewski, M. | Zaborowska, L. | +6

102

Integrating New Effectiveness Data Into US Food and Drug Administration-Approved Drug Labeling

enthalten in: JAMA internal medicine | 2021

von Gyawali, B. | Darrow, J. | Kesselheim, A.

103

Financial Toxicity Among Patients with Prostate, Bladder, and Kidney Cancer : A Systematic Review and Call to Action

enthalten in: European urology oncology | 2021

von Bhanvadia, S. | Psutka, S. | Burg, M. | +8

104

Health System Preparedness for COVID-19 and Its Impacts on Frontline Health-Care Workers in Nepal : A Qualitative Study Among Frontline Health-Care Workers and Policy-Makers

enthalten in: Disaster medicine and public health preparedness | 2021

von Shrestha, N. | Mishra, S. | Ghimire, S. | +8

105

Assessing the benefit of cancer drugs approved by the European Medicines Agency using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale over time

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Thomson, S. | Witzke, N. | Gyawali, B. | +5

106

Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis

enthalten in: Targeted oncology | 2021

von Strzebonska, K. | Wasylewski, M. | Zaborowska, L. | +6

107

Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis

enthalten in: Targeted oncology | 2021

von Strzebonska, K. | Wasylewski, M. | Zaborowska, L. | +6

108

Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis

enthalten in: Targeted oncology | 2021

von Strzebonska, K. | Wasylewski, M. | Zaborowska, L. | +6

109

Industry payments to US physicians for cancer therapeutics : An analysis of the 2016-2018 open payments datasets

enthalten in: Journal of cancer policy | 2021

von Meyers, D. | Chisamore, T. | McInnes, M. | +3

110

Why Not Adore ADAURA?-The Trial We Need vs the Trial We Got

enthalten in: JAMA oncology | 2021

von West, H. | Gyawali, B.